Long-term antibiotic therapy does not significantly improve quality of life in patients with persistent symptoms attributed to Lyme disease, according to a study today in the New England Journal of Medicine.
The Northern Hemisphere's 2015-16 flu vaccine has shown significant protection against circulating 2009 H1N1 strains in Canada, according to an interim report today from Canadian researchers in Eurosurveillance.
PulseNet, the national lab network that links cases of foodborne disease by tracking genetic fingerprints of pathogens, saves an estimated $500 million and prevents 270,000 disease cases a year, according to an economic evaluation today in the American Journal of Preventive Medicine.
Saudi Arabia's Ministry of Health (MOH) today confirmed two new MERS-CoV cases, both primary infections in men who had indirect contact with camels.
The first MERS-CoV (Middle East respiratory syndrome coronavirus) case-patient is a 60-year-old Saudi man from the southern city of Najran. He is in stable condition and is not a healthcare worker, the MOH said.
Protection against the H1N1 strain was 51%, compared with 76% to 79% against B strains.
A new analysis of data from a large randomized trial suggests that the high-dose (HD) flu vaccine is more protective in seniors than the standard-dose (SD) vaccine, and this benefit is not affected by which formulation seniors received in the previous flu season.
Saudi Arabia today reported two fatal MERS-CoV cases in elderly men in the same city, Al-Kharj in the central part of the country, where two other cases were reported in recent weeks.
Influenza-related hospitalization rates and high poverty levels showed a "robust" correlation, according to an analysis of data from 14 states during the 2010-11 to 2011-12 flu seasons published today in Morbidity and Mortality Weekly Report (MMWR).
China has reported 17 more H7N9 avian influenza cases, at least three of them fatal, according to official reports from local, state, and federal government health departments.
Although complete flu vaccine coverage increased dramatically from 2002-03 to 2011-12 in kids under 2 years old, it still falls well below 50% and is even lower in minority groups, according to a study yesterday in Pediatrics.